SEC Form 4 · accession 0001213900-18-001237
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrence Hamilton
Officer — SVP of Sales
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock GrantRestricted Stock GrantF1,F2,F3 | — | Feb 1, 2018 | A | 50,000 | A | — | — | Common Stock | 50,000 | 450,000 | D |
Explanation of responses
- F1Each restricted stock grant represents a contingent right to receive one share of the Issuer's common stock.
- F2The reporting person received a restricted stock grant that may vest on either February 1, 2019 or February 1, 2020, subject to achievement of the Issuer's year-end revenue performance goals.
- F3Not applicable.